Boston, Massachusetts
United States
35
2022-11-17
30
2024-01-16
These are the the leading inventors for applications assigned to ACETYLON PHARMACEUTICALS, INC.:
ACETYLON PHARMACEUTICALS, INC. based in Boston, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Pharmaceutical combinations comprising a histone deacetylase inhibitor and an aurora kinase inhibitor and methods of use thereof
#2 | 2022-11-10 ✅ Patent 12,053,468 granted on 2024-08-06Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof
#3 | 2020-10-15 ✅ Patent 11,298,354 granted on 2022-04-12Methods of use and pharmaceutical combinations of HDAC inhibitors with BET inhibitors
#4 | 2020-02-13 ✅ Patent 11,357,776 granted on 2022-06-14Pharmaceutical combinations comprising a histone deacetylase inhibitor and an aurora kinase inhibitor and methods of use thereof
#5 | 2020-01-30 ✅ Patent 11,617,750 granted on 2023-04-04Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
#6 | 2020-01-09 ✅ Patent 10,927,072 granted on 2021-02-23Phenyl and pyridinyl hydroxamic acids
#7 | 2019-10-24 ✅ Patent 11,998,546 granted on 2024-06-04Pharmaceutical combinations comprising a histone deacetylase inhibitor and epothilone and methods of use thereof
#8 | 2019-09-19 ✅ Patent 11,337,975 granted on 2022-05-24Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof
#9 | 2019-09-19 ✅ Patent 11,497,746 granted on 2022-11-15Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (PD-L1) inhibitor and methods of use thereof
#10 | 2019-08-29 ✅ Patent 11,666,568 granted on 2023-06-06Pharmaceutical combinations comprising a histone deacetylase inhibitor and a BCL-2 inhibitor and methods of use thereof
#11 | 2019-02-14 ✅ Patent 11,311,540 granted on 2022-04-26Increasing expression of interferon regulated genes with combinations of histone deacetylase inhibitors and immunomodulatory drugs
#12 | 2018-05-10 ✅ Patent 10,370,324 granted on 2019-08-06Phenyl and pyridinyl hydroxamic acids
#13 | 2018-02-08 ✅ Patent 11,324,744 granted on 2022-05-10Methods of use and pharmaceutical combinations of histone deacetylase inhibitors and CD20 inhibitory antibodies
#14 | 2017-11-16 ✅ Patent 10,648,038 granted on 2020-05-12Biomarkers to identify patients that will respond to treatment and treating such patients
#15 | 2017-04-06 ✅ Patent 9,884,850 granted on 2018-02-06Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
#16 | 2017-01-26 ✅ Patent 10,722,512 granted on 2020-07-28Combinations of histone deacetylase inhibitors and either HER2 inhibitors or PI3K inhibitors
#17 | 2017-01-05 ✅ Patent 10,464,906 granted on 2019-11-05Crystalline forms of a histone deacetylase inhibitor
#18 | 2016-12-08 ✅ Patent 10,144,714 granted on 2018-12-04Methods of making protein deacetylase inhibitors
#19 | 2016-08-11TREATMENT OF DISEASES CAUSED BY ABNORMAL LYMPHOCYTE FUNCTION WITH AN HDAC6 INHIBITOR
#20 | 2016-03-10 ✅ Patent 9,421,212 granted on 2016-08-23Selective HDAC1 and HDAC2 inhibitors
#21 | 2016-02-04 ✅ Patent 9,833,466 granted on 2017-12-05Treatment of leukemia with histone deacetylase inhibitors
#22 | 2015-10-22 ✅ Patent 9,562,013 granted on 2017-02-07Selective HDAC3 inhibitors
#23 | 2015-08-27 ✅ Patent 9,464,073 granted on 2016-10-11Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
#24 | 2015-06-25HISTONE DEACETYLASE 6 (HDAC6) BIOMARKERS IN MULTIPLE MYELOMA
#25 | 2015-06-04 ✅ Patent 9,949,972 granted on 2018-04-24Combinations of histone deacetylase inhibitors and immunomodulatory drugs
#26 | 2015-04-16 ✅ Patent 9,278,963 granted on 2016-03-08Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
#27 | 2015-04-16HDAC Inhibitors, Alone Or In Combination With PI3K Inhibitors, For Treating Non-Hodgkin's Lymphoma
#28 | 2015-04-16COMBINATIONS OF HISTONE DEACETYLASE INHIBITORS AND IMMUNOMODULATORY DRUGS
#29 | 2015-04-09 ✅ Patent 9,403,779 granted on 2016-08-02Combinations of histone deacetylase inhibitors and either Her2 inhibitors or PI3K inhibitors
#30 | 2014-12-04HISTONE DEACETYLASE (HDAC) BIOMARKERS IN MULTIPLE MYELOMA
#31 | 2014-09-04 ✅ Patent 9,139,583 granted on 2015-09-22Selective HDAC3 inhibitors
#32 | 2014-08-28 ✅ Patent 9,096,549 granted on 2015-08-04Selective HDAC3 inhibitors
#33 | 2014-05-08 ✅ Patent 9,145,412 granted on 2015-09-29Selective HDAC1 and HDAC2 inhibitors
#34 | 2014-01-09 ✅ Patent 9,663,825 granted on 2017-05-30Biomarkers to identify patients that will respond to treatment and treating such patients
#35 | 2012-05-17 ✅ Patent 8,614,223 granted on 2013-12-24Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
Also check out ACETYLON PHARMACEUTICALS, INC.'s (Boston, United States) applicant profile with 31 patent applications submitted.
84161 ⎘